FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate (Q36644468)
Jump to navigation
Jump to search
scientific article published on 18 December 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate |
scientific article published on 18 December 2012 |
Statements
1 reference
FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate (English)
1 reference
Shelby Kutty
1 reference
Lin Piao
1 reference
Vaninder K Sidhu
1 reference
Yong-Hu Fang
1 reference
John J Ryan
1 reference
Kishan S Parikh
1 reference
Zhigang Hong
1 reference
Peter T Toth
1 reference
Erik Morrow
1 reference
Gary D Lopaschuk
1 reference
Stephen L Archer
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference